Back to Search
Start Over
Osteoporosis-treating parathyroid hormone peptides: What are they? What do they do? How might they do it?
- Source :
-
Current opinion in investigational drugs (London, England : 2000) [Curr Opin Investig Drugs] 2006 Apr; Vol. 7 (4), pp. 349-59. - Publication Year :
- 2006
-
Abstract
- The first experiments demonstrating parathyroid hormone's (PTH's) dramatic bone-building activity in rat pups, using a bovine parathyroid extract called parathormone were reported 74 years ago. Over the next decades, the native parathyroid hormone (human (h)PTH(1-84)) was purified and two of its fragments (hPTH(1-34) and (Leu27)cycloGlu22-Lys26hPTH(1-31)NH2) have been developed for the treatment of osteoporosis. One of these, recombinant (r)hPTH(1-34), is now on the market under the trade name of Forteo. The native hormone has also completed clinical trials and (Leu27)cycloGlu22-Lys26hPTH(1-31)NH2 is in phase II clinical trials under the trade name Ostabolin-C. All three of these peptides potently stimulate bone growth, reinforce bone microstructure weakened by estrogen deprivation and reduce further fracturing. Furthermore, future studies may demonstrate that these peptides also promote the repair of existing fractures and implant anchorage in both healthy and osteoporotic humans. PTHs have the potential to become more successful by using cost-cutting, but still effective, cyclical treatment regimens and by formulating them for non-injectable delivery. This review will discuss the identification of PTH peptides, how they function and their future role in the treatment of osteoporosis.
- Subjects :
- Animals
Bone Density drug effects
Bone Development drug effects
Glycogen Synthase Kinase 3 physiology
Glycogen Synthase Kinase 3 beta
Humans
Osteoporosis physiopathology
Parathyroid Hormone pharmacology
Peptide Fragments therapeutic use
Receptor, Parathyroid Hormone, Type 1 physiology
Tomography, X-Ray Computed
beta Catenin physiology
Osteoporosis drug therapy
Parathyroid Hormone therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1472-4472
- Volume :
- 7
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Current opinion in investigational drugs (London, England : 2000)
- Publication Type :
- Academic Journal
- Accession number :
- 16625822